BMY   $58.11  -2.12% Market Closed After Close 58.23 0.21%

Bristol-Myers Squibb Company

EMA (20): 2026-03-10 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2025-11-20 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (100): 2025-11-24 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: up-crossing the middle level.

Trend Type turning up
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -1.26%
EMA (20) date of signal March 10, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 29.23%
EMA (50) date of signal Nov. 20, 2025, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 24.31%
EMA (100) date of signal Nov. 24, 2025, 3 a.m.
RSI Signals bearish
RSI (14) Yield 0.0
RSI (14) date of signal March 18, 2026, 3 a.m.
MACD Signals bullish weakening
MACD Yield -3.02%
MACD date of signal March 3, 2026, 3 a.m.
Stochastic Signals bullish
Stochastic Yield 0.0
Stochastic date of signal March 18, 2026, 3 a.m.
Updated March 19, 2026, 11 p.m.